Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1446282-35-4
32405-88-2
731779-91-2 | (3-[4-(Trifluoromethyl)phenyl]phenyl)sulfonylchloride | AA00ICAG | MFCD01631887
74450-59-2 | Ethyl 4-amino-2-methylbenzoate | AA00ICG3 | MFCD08458830
77458-31-2 | 1-(4-Fluorophenyl)-1h-pyrazol-4-ol | AA00ICS5 | MFCD23111092
79277-27-3 | Thifensulfuron-methyl | AA00ICY3 | MFCD00468118
812639-28-4 | 6-Methoxy-3-pyridineethanamine hydrochloride | AA00ID3K | MFCD18802402
83799-24-0 | 2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid | AA00ID92 | MFCD00871892
850335-09-0 | Methyl 4-hydroxy-3-methyl-5-nitrobenzoate | AA00IDFU | MFCD27929790
855715-22-9 | 2-Chloro-n-(5-chloro-2-fluorophenyl)acetamide | AA00IDMO | MFCD06655065
860649-71-4 | 2-[4-(Trifluoromethyl)phenoxy]acetohydrazide | AA00IDTC | MFCD04035657